GCANPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.14+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.13M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 17, 2026 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Sep 17, 2026 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Aug 14, 2026(first seen in filings) | 1-for-1400 reverse | Earlier per-share figures multiplied by 1400 |
| Nov 12, 2025(first seen in filings) | 1-for-1499 reverse | Earlier per-share figures multiplied by 1499 |
| Oct 17, 2025 | 1-for-1500 reverse | Earlier per-share figures multiplied by 1500 |